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Sorting nexin 1 (SNX1) and SNX2 are the mammalian homologues of the yeast Vps5p retromer component that functions
in endosome-to-Golgi trafficking. SNX1 is also implicated in endosome-to-lysosome sorting of cell surface receptors,
although its requirement in this process remains to be determined. To assess SNX1 function in endocytic sorting of
protease-activated receptor-1 (PAR1), we used siRNA to deplete HeLa cells of endogenous SNX1 protein. PAR1, a
G-protein-coupled receptor, is proteolytically activated by thrombin, internalized, sorted predominantly to lysosomes,
and efficiently degraded. Strikingly, depletion of endogenous SNX1 by siRNA markedly inhibited agonist-induced PAR1
degradation, whereas expression of a SNX1 siRNA-resistant mutant protein restored agonist-promoted PAR1 degradation
in cells lacking endogenous SNX1, indicating that SNX1 is necessary for lysosomal degradation of PAR1. SNX1 is known
to interact with components of the mammalian retromer complex and Hrs, an early endosomal membrane-associated
protein. However, activated PAR1 degradation was not affected in cells depleted of retromer Vps26/Vps35 subunits, Hrs
or Tsg101, an Hrs-interacting protein. We further show that SNX2, which dimerizes with SNX1, is not essential for
lysosomal sorting of PAR1, but rather can regulate PAR1 degradation by disrupting endosomal localization of endoge-
nous SNX1 when ectopically expressed. Together, our findings establish an essential role for endogenous SNX1 in sorting
activated PAR1 to a distinct lysosomal degradative pathway that is independent of retromer, Hrs, and Tsg101.
INTRODUCTION
Mammalian sorting nexins (SNXs) are a group of highly
diverse cellular proteins defined by the presence of a phos-
pholipid-binding domain termed the phox homology (PX)
domain (Worby and Dixon, 2002). SNX1 and SNX2 are the
mammalian homologues of the yeast vacuole protein-sort-
ing molecule Vps5p (Haft et al., 1998). Vps5p interacts with
Vps17p and forms part of a retromer complex comprised of
five distinct proteins, including Vps35p, Vps29p, and
Vps26p. The yeast retromer complex is required for retrieval
of Vps10p receptor from prevacuolar endosomes back to the
trans-Golgi network (TGN) (Horazdovsky et al., 1997; Noth-
wehr and Hindes, 1997; Seaman et al., 1998). The retrograde
trafficking of Vps10p is essential for delivery of newly syn-
thesized hydrolases to the vacuole, an organelle equivalent
to the mammalian lysosome. The mammalian homologues
of the retromer subunits have now been identified (with the
exception of Vps17) and appear to have distinct functions in
various cell types. Several recent studies indicate that mam-
malian retromer subunits Vps26, Vps35, and SNX1 are es-
sential for retrieval of the cation-independent mannose
6-phosphate receptor (CI-MPR), the functional homologue
of Vps10p, in HeLa cells (Arighi et al., 2004; Carlton et al.,
2004; Seaman, 2004), suggesting that retromer function in
retrograde trafficking of a lysosomal hydrolase receptor re-
mained conserved in mammalian cells. However, the retro-
mer Vps35-Vps29-Vps26 subcomplex has also been shown
to regulate pIgR-pIgA transcytosis in MDCK cells (Verges et
al., 2004), indicating a role for retromer in protein sorting in
polarized epithelial cells. Moreover, our recent work in mice
demonstrates that mammalian retromer complexes, contain-
ing SNX1 and SNX2, have an essential function in embry-
onic development that does not involve regulation of CI-
MPR trafficking (Griffin et al., 2005). Thus, retromer activity
appears to have evolved considerably from yeast and regu-
lates complex and distinct cellular processes in different
mammalian tissues.
SNX1 was originally identified in a yeast two-hybrid
screen using the cytoplasmic tail of the epidermal growth
factor receptor (EGFR) (Kurten et al., 1996). A function for
SNX1 in endosome-to-lysosome trafficking was then sug-
gested based on studies in which SNX1 overexpression en-
hanced EGFR degradation and SNX1 deletion mutants in-
hibited EGFR degradation (Kurten et al., 1996; Zhong et al.,
2002). Moreover, endogenous SNX1 localizes predominantly
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to early endosomes by binding to PtdIns(3)P, a phospholipid
highly enriched in early endosomal membranes (Cozier et
al., 2002; Zhong et al., 2002). SNX1 also interacts with Hrs, an
early endosomal membrane-associated protein (Chin et al.,
2001; Raiborg et al., 2001). Hrs associates with Tsg101 and is
essential for lysosomal sorting of EGFR (Bishop et al., 2002;
Lu et al., 2003). Other cell surface integral membrane recep-
tors, including nutrient receptors and receptor tyrosine ki-
nases, also associate with SNX1 when heterologously ex-
pressed (Haft et al., 1998). However, we and others have
recently shown that neither endogenous SNX1 nor SNX2 is
required for lysosomal degradation of EGFR (Carlton et al.,
2004; Gullapalli et al., 2004). Thus, whether endogenous
SNX1 function is essential for endosome-to-lysosome sort-
ing of cell surface receptors in mammalian cells remains to
be determined.
Intracellular trafficking of G protein-coupled receptors
(GPCRs), which comprises the largest family of cell surface
receptors in the mammalian genome (Pierce et al., 2002),
controls the temporal and spatial aspects of receptor signal-
ing. However, the mechanisms that mediate trafficking of
GPCRs through the endocytic system remain poorly de-
fined. A protein-protein interaction screen using SNX1 and a
library of 59 GPCR carboxyl terminal tails revealed that
SNX1 is capable of interacting with at least 10 distinct
GPCRs in vitro (Heydorn et al., 2004). We also previously
demonstrated that SNX1 associates with protease-activated
receptor-1 (PAR1), a GPCR for thrombin, and that a deletion
mutant of SNX1 blocked lysosomal degradation of activated
PAR1 (Wang et al., 2002). Because activated PAR1 is rapidly
internalized, sorted predominantly to lysosomes, and de-
graded with remarkable efficiency (Trejo et al., 1998; Trejo
and Coughlin, 1999), it is a useful model for dissecting the
molecular mechanism(s) responsible for GPCR lysosomal
sorting. Toward elucidating the molecular basis of GPCR
trafficking and toward determining whether SNX1 functions
in endosome-to-lysosome sorting in mammalian cells, we
examined whether endogenous SNX1 functions in lysoso-
mal degradation of activated PAR1. Our studies reveal for
the first time that endogenous SNX1 is essential for sorting
activated PAR1 to a distinct lysosomal degradative pathway
that does not require retromer, Hrs, or Tsg101 activity.
MATERIALS AND METHODS
Antibodies and Reagents
Agonist peptide SFLLRN was synthesized as the carboxyl amide and purified
by reverse phase high-pressure liquid chromatography (UNC Peptide Facil-
ity, Chapel Hill, NC). The epidermal growth factor (EGF) ligand and leupep-
tin were purchased from Sigma (St. Louis, MO). Rabbit anti-PAR1 antibody
was generated against the amino-terminal peptide sequence-YEPF-
WEDEEKNESGLTEYC, as previously described (Hung et al., 1992). Anti-
EGFR mouse monoclonal LA22 antibody was from Upstate Biotechnology
(Lake Placid, NY). Monoclonal M1 and M2 anti-FLAG antibodies were pur-
chased from Sigma. Mouse anti-SNX1 antibody was purchased from BD
Transduction Laboratories (Lexington, KY). Anti-myc rabbit polyclonal anti-
body (A-14) and mouse anti-myc (9E10) were from Santa Cruz Biotechnology
(Santa Cruz, CA). The rabbit polyclonal anti-SNX antibodies were generated
against full-length SNX1 or SNX2 expressed as a glutathione S-transferase
fusion protein (Haft et al., 1998). Anti-actin antibody was obtained from
Sigma. The rabbit polyclonal anti-Vps26 and anti-Vps35 antibodies were
generated as described previously (Haft et al., 2000). Anti-CI-MPR mouse
monoclonal antibody was from Research Diagnostics. Monoclonal anti-Hrs
antibody was purchased from Alexis Biochemicals and mouse anti-Tsg101–
4A10 antibody was from GeneTex. Anti-lysosomal-associated membrane pro-
tein-1 (LAMP1) H4A3 mouse antibody was obtained from the Developmental
Studies Hybridoma Bank (University of Iowa, Iowa City, IA). The secondary
antibodies, goat anti-mouse- and anti-rabbit-conjugated to horseradish per-
oxidase, were from Bio-Rad (Richmond, CA). Alexa488- and Alexa594-conju-
gated goat anti-mouse and anti-rabbit antibodies were obtained from Molec-
ular Probes (Eugene, OR).
Cell Lines and cDNAs
HeLa cells stably expressing an amino-terminal FLAG-tagged PAR1 were
grown and maintained as described previously (Trejo et al., 2000). The N-
terminal myc-tagged SNX1 and SNX2 cDNAs were gifts from C. R. Haft
(National Institute of Diabetes and Digestive and Kidney Diseases, National
Institutes of Health) and have been described previously (Haft et al., 1998). A
myc-tagged SNX1 small interfering RNA (siRNA)-resistant mutant cDNA
was generated by introducing a silent mutation at codon Ile-549 (ATC3ATT)
using Quick Change site-directed mutagenesis kit (Stratagene, La Jolla, CA),
and specific mutations were confirmed by dideoxy sequencing. Ile-549 is
located within the region targeted by SNX1 siRNA3 oligo. To generate
SNX1/2 chimeras, a BsiWI site was introduced in the myc-SNX1 and myc-
SNX2 cDNAs just 5 to the sequence encoding the PX domain (SKPQRTYE for
SNX1 and VIFDRTRE for SNX2, where the location corresponding to the
BsiWI sites are underlined). A second site BspEI was then introduced just 3 to
the PX domain (TQTLSGAG for SNX1 and TQALSGAG for SNX2, where the
location corresponding to the BspEI sites are underlined). These BsiWI and
BspEI sites were then used to exchange cDNA fragments encoding the N-
terminus/PX domain or PX domain/C-terminus of SNX1 and SNX2 (see
Figure 7). Mutations in all constructs were confirmed by dideoxy sequencing.
siRNAs Transient Transfection
HeLa cells plated at 5.0  105 cells per well of 6-well dishes or at 1.25  105
cells per well of 12-well dishes were grown overnight. Cells were then
transiently transfected with 100 nM of specific siRNAs using LipofectAMINE
2000 according to the manufacturer’s instructions (Invitrogen, Carlsbad, CA),
and experiments were performed 48 h later or after two consecutive 72-h
siRNA transfections with Vps26 siRNA as previously described (Arighi et al.,
2004). siRNAs were from Dharmacon (Lafayette, CO) and were designed to
target the following specific mRNA sequences: SNX1 siRNA3 (5-CCA CGU
GAU CAA GUA CCU U-3), SNX2 siRNA2 (5-GAU AGA CCA GUU ACA
UCA A-3), hVps26 siRNA (5-CUC UAU UAA GAU GGA AGU G-3), Hrs
siRNA (5-CGA CAA GAA CCC ACA CGU C-3), Tsg101 siRNA (5-CCU
CCA GUC UUC UCU CGU C-3) and a nonspecific (ns) siRNA (5-GGC UAC
GUC CAG GAG CGC ACC-3) was used as a negative control.
Transient Transfections
HeLa cells were plated at 5.0  105 cells per well in 6-well dishes or at 1.25 
105 cells per well in 12-well dishes and grown overnight. Cells were then
transiently transfected with a total of 2 g of plasmid DNA per well of a
6-well dish or 0.8 g plasmid DNA per well of a 12-well dish using Lipo-
fectAMINE reagent according to the manufacturer’s instructions (Invitrogen).
All experiments were performed 48 h after transfection.
Coimmunoprecipitation and Immunoblotting
HeLa cells stably expressing FLAG-tagged PAR1 plated at 5.0  105 cells per
well in a six-well dish were transiently transfected and grown for 48 h. Cells
were lysed and immunoprecipitated with M2 anti-FLAG antibody, as de-
scribed previously (Wang et al., 2002). Immunoprecipitates were resolved by
9 or 12% SDS-PAGE and transferred, and membranes were then incubated
overnight at 4°C with anti-PAR1 rabbit polyclonal antibody. Cell lysates were
run in parallel and immunoblotted for SNX1, SNX2, Vps26, Vps35, Hrs,
Tsg101, myc or actin proteins. HeLa cells plated at 1.25  105 cells per well of
12-well dishes were transiently transfected, lysed, and immunoblotted for
endogenous EGFR. Membranes were washed, incubated with species-specific
secondary antibodies-conjugated to horseradish peroxidase, and washed
again. Immunoblots were then developed using enhanced chemilumines-
cence (Amersham Biosciences, Piscataway, NJ), imaged by autoradiography,
and quantitated using a Fluor-S MultiImager (Bio-Rad, Richmond, CA).
Immunofluorescence Confocal Microscopy
HeLa cells plated at 1.5  105 on fibronectin-coated glass coverslips in 12-well
dishes were transiently transfected and grown for 48 h. Cells were fixed and
processed for microscopy as described previously (Trejo et al., 2000). Colocal-
ization of PAR1 with LAMP1 was assessed in cells that were pretreated with
2 mM leupeptin for 1 h. Confocal images were acquired using a Fluoview 300
laser scanning confocal imaging system (Olympus) configured with an IX70
fluorescence microscope fitted with a PlanApo 60 oil objective (Olympus).
Fluorescent images, X-Y section at 0.28 m, were collected sequentially at
800  600 resolution with 2 optical zoom. Some images (see Figures 8 and
9) were collected using an Olympus DSU spinning disk confocal microscope
configured with a PlanApo 60 oil objective and Hamamatsu ORCA-ER
digital camera. Fluorescent images of X-Y sections at 0.15 m were collected
sequentially using Intelligent Imaging Innovations Slidebook 4.1 software.
The final composite images were created using Adobe Photoshop CS (Adobe
Systems, San Jose, CA).
Internalization Assay
HeLa cells stably expressing PAR1 plated at a density of 1.0  105 cells in
24-well dishes were transiently transfected with siRNA and grown for 48 h.
SNX1 Regulation of GPCR Trafficking
Vol. 17, March 2006 1229
Cells were incubated with or without agonist for various times at 37°C. Cells
were fixed with 4% paraformaldehyde for 5 min at 4°C, washed, and then
incubated with M1 anti-FLAG antibody diluted in DMEM containing 1
mg/ml BSA, 1 mM CaCl2, 10 mM HEPES, pH 7.4, for 1 h at 25°C. Cells were
washed and then incubated with horseradish peroxidase-conjugated goat
anti-mouse secondary antibody for 1 h at 25°C. The amount of bound horse-
radish peroxidase-goat anti-mouse secondary antibody was determined by
incubation with one-step ABTS (2,2-azino-bis-3-ethylbenz-thiazoline-6-sul-
fonic acid; Pierce, Rockford, IL) substrate for 10–20 min at 25°C. An aliquot
was removed and the optical density was determined at 405 nm using a
Molecular Devices SpectraMax Plus microplate reader (Sunnyvale, CA).
RESULTS
SNX1 Is Necessary for Sorting Activated PAR1 to a
Degradative Pathway
Genetic and biochemical evidence indicate that SNX1 is part
of a “retromer” complex that functions in endosome-to-TGN
retrograde trafficking (Horazdovsky et al., 1997; Nothwehr
and Hindes, 1997; Seaman et al., 1998; Carlton et al., 2004).
SNX1 has also been implicated in endosome-to-lysosome
sorting of cell surface receptors in mammalian cells; how-
ever, whether SNX1 is required in this process remains to be
determined. Toward defining the functional importance of
SNX1 in PAR1 trafficking, we used siRNA to deplete HeLa
cells of endogenous SNX1 protein. Endogenous SNX1 ex-
pression was virtually abolished in cells transfected with
SNX1-specific siRNA compared with nonspecific (ns) con-
trol siRNA-treated cells (Figure 1, middle panels). To deter-
mine whether SNX1 was necessary for agonist-induced
PAR1 degradation, HeLa cells stably expressing FLAG-
tagged PAR1 were transiently transfected with control or
SNX1 siRNA, and PAR1 degradation was assessed. In con-
trol siRNA-treated cells, a significant 60% loss of receptor
protein was observed after 90-min exposure to PAR1-spe-
cific agonist peptide SFLLRN (Figure 1). These findings are
consistent with the extent of agonist-induced PAR1 degra-
dation typically observed in these cells (Trejo et al., 2000). In
contrast, activated PAR1 degradation was markedly inhib-
ited in cells lacking endogenous SNX1 (Figure 1); only 8%
of receptors were degraded after agonist treatment. These
findings suggest that SNX1 is necessary for agonist-induced
PAR1 degradation.
We next determined whether expression of a siRNA-re-
sistant SNX1 mutant protein could restore agonist-induced
PAR1 degradation in cells lacking endogenous SNX1. PAR1-
expressing HeLa cells were cotransfected with control
siRNA and pcDNA or with SNX1 siRNA and either pcDNA,
wild-type myc-SNX1 or myc-SNX1 siRNA-resistant mutant
cDNAs. A significant decrease in endogenous SNX1 and
wild-type myc-SNX1 protein was observed in cells trans-
fected with SNX1 siRNA compared with control siRNA-
treated cells (Figure 2, lanes 1–6). In contrast, expression of
myc-SNX1 siRNA-resistant mutant protein was unaffected
in SNX1 siRNA-transfected cells, as expected (Figure 2, lanes
7 and 8). A 90-min exposure to agonist peptide SFLLRN
caused a marked 50% decrease in PAR1 protein in control
siRNA-transfected cells (Figure 2, lanes 1 and 2). By contrast,
activated PAR1 failed to efficiently degrade in cells cotrans-
fected with SNX1 siRNA and either pcDNA or wild-type
myc-SNX1 (Figure 2, lanes 3–6), indicating that SNX1 is
required for agonist-induced PAR1 degradation. Strikingly,
however, coexpression of SNX1 siRNA-resistant mutant
protein together with SNX1 siRNA restored the ability of
agonist to induce a significant 60% degradation of PAR1
protein (Figure 2, lanes 7 and 8). Together these observations
strongly suggest that SNX1 is necessary for sorting activated
PAR1 to a lysosomal degradative pathway in mammalian
cells.
To determine whether SNX1 siRNA blocked PAR1 degra-
dation by inhibiting receptor internalization, we assessed
agonist-induced loss of cell surface PAR1 quantitatively by
ELISA. PAR1-expressing HeLa cells transfected with control
or SNX1 siRNA were incubated with agonist for various
times, and the amount of PAR1 remaining on the cell surface
was then measured. In control siRNA-treated cells, agonist
induced rapid PAR1 internalization from the cell surface
within 10 min (Figure 3A), and receptor continued to slowly
internalize to 50% loss of cell surface PAR1 after 30 min of
agonist exposure. The addition of agonist caused a similar
decrease in PAR1 internalization at various times in SNX1
siRNA-treated cells (Figure 3A), which were depleted of
endogenous SNX1 protein as assessed by immunoblot and
immunofluorescence microscopy (Figure 3C). Studies of sta-
ble PAR1-expressing HeLa cells using immunofluorescence
microscopy were consistent with a SNX1-independent reg-
ulation of receptor internalization. In control siRNA-treated
cells, 10-min incubation with agonist caused PAR1 to redis-
tribute from the cell surface into endocytic vesicles (Figure
3B, a and b). Similar results were observed in cells trans-
fected with SNX1 siRNA after 10-min agonist exposure (Fig-
ure 3B, d and e). We then examined whether SNX1 was
necessary for delivery of PAR1 from an endosomal to a
lysosomal compartment by examining PAR1 endosomal ac-
cumulation after prolonged agonist exposure. After 60 min
of agonist incubation, PAR1-positive endosomes were no
Figure 1. SNX1 is essential for agonist-induced PAR1 degradation.
HeLa cells stably expressing FLAG-tagged PAR1 were transiently
transfected with nonspecific (ns) or SNX1 siRNA and then incu-
bated in the absence or presence of 100 M SFLLRN for 90 min at
37°C. Cells were lysed and immunoprecipitated with M2 anti-FLAG
antibody, and the amount of PAR1 remaining was detected by
immunoblot analysis using an anti-PAR1 polyclonal antibody (top
panel). Cell lysates were immunoblotted for expression of endoge-
nous SNX1 or actin to control for equal loading (bottom panels). The
data (mean  SE) in the bar graph are expressed as a percentage of
PAR1 remaining compared with untreated control cells. Data were
determined for each transfection condition and represent the aver-
age of three separate experiments.
A. Gullapalli et al.
Molecular Biology of the Cell1230
longer apparent in control siRNA-transfected cells (Figure
3Bc), consistent with activated PAR1 lysosomal sorting and
degradation. By contrast, in SNX1 siRNA-transfected cells,
PAR1 containing endosomes were apparent and easily de-
tected after 60 min of agonist exposure (Figure 3Bf). Thus,
activated PAR1 accumulates in endosomes and fails to effi-
ciently sort to a degradative pathway in cells depleted of
endogenous SNX1, suggesting a critical function for SNX1 in
endosome-to-lysosome trafficking of PAR1.
Lysosomal Degradation of PAR1 Is Independent of
Retromer, Hrs, and Tsg101 Activity
Recent studies indicate that SNX1 functions as part of the
mammalian retromer complex that mediates endosome-to-
TGN retrograde trafficking of CI-MPR (Carlton et al., 2004).
To determine whether SNX1 regulation of PAR1 trafficking
involves retromer activity, we used siRNA to deplete cells of
endogenous Vps26, a protein subunit important for main-
taining retromer activity. PAR1-expressing HeLa cells were
transfected with control or Vps26 siRNA, and the effects on
PAR1 degradation were assessed. In Vps26 siRNA-treated
cells, the amounts of Vps26 and Vps35, a core retromer
subunit protein, were substantially reduced compared with
control siRNA-treated cells (Figure 4A), whereas endoge-
nous SNX1 and SNX2 expression were unaffected (Figure
4C, bottom panels). In both control and Vps26 siRNA-
treated cells, agonist induced a similar 50–60% degrada-
tion of PAR1 protein (Figure 4A), suggesting that Vps26 is
not essential for activated PAR1 degradation. To confirm
that PAR1 degradation is due to lysosomal sorting in Vps26
knockdown cells, we examined activated PAR1 colocaliza-
tion with the lysosomal-associated membrane protein-1
(LAMP1) in the presence of leupeptin, a classic inhibitor of
lysosomal proteases. Activated PAR1 accumulated in vesi-
cles in the presence of leupeptin after 60 min of agonist
exposure and extensively colocalized with LAMP1 in both
control and Vps26 siRNA-treated cells (Figure 4B), indicat-
ing that PAR1 is targeted to lysosomes under these condi-
tions. In the absence of leupeptin, LAMP1-positive vesicles
containing PAR1 were not apparent, consistent with lysoso-
mal sorting and degradation of activated receptor as we
previously reported (Trejo and Coughlin, 1999). To ensure
that depletion of Vps26 by siRNA disrupted retromer func-
tion in retrograde trafficking, we examined the stability of
CI-MPR using conditions that we, and others, have recently
reported (Arighi et al., 2004; Griffin et al., 2005). HeLa cells
transfected with control or Vps26 siRNA were treated with
or without cycloheximide, an inhibitor of protein synthesis,
and the amount of CI-MPR protein remaining was then
determined using immunoblot analysis. In Vps26 siRNA-
treated cells, the amount of CI-MPR protein was reduced by
50% compared with control siRNA-treated cells (Figure
4C). These findings suggest that in Vps26-depleted cells
retromer fails to retrieve CI-MPR from endosomes resulting
in lysosomal sorting and degradation of CI-MPR, consistent
with recently reported studies (Arighi et al., 2004; Seaman,
2004). Together, these studies suggest that SNX1 functions
independent of retromer to mediate lysosomal sorting and
degradation of activated PAR1.
Hrs associates with Tsg101 and regulates endosome-to-
lysosome sorting of EGFR (Bishop et al., 2002; Lu et al., 2003).
Hrs has also been shown to directly interact with SNX1
(Chin et al., 2001), raising the possibility that Hrs and Tsg101
might function in lysosomal sorting of PAR1. To assess the
function of these proteins in PAR1 trafficking, we depleted
HeLa cells of endogenous Hrs and Tsg101 proteins using
siRNA and assessed PAR1 degradation. The expression of
endogenous Hrs and Tsg101 proteins was virtually abol-
ished after incubation with their specific siRNAs compared
with control siRNA-treated cells (Figure 5A, middle panels).
However, Tsg101 siRNA also caused partial degradation of
Hrs protein, although the mechanism by which this occurs is
unknown. In cells lacking either Hrs or Tsg101 proteins,
agonist induced a significant 60–70% degradation of PAR1
Figure 2. Ectopic expression of SNX1
siRNA-resistant mutant restores agonist-in-
duced PAR1 degradation in cells lacking en-
dogenous SNX1. HeLa cells stably expressing
FLAG-tagged PAR1 were transiently cotrans-
fected with either nonspecific (ns)-siRNA
and pcDNA (lanes 1 and 2) or with SNX1
siRNA and pcDNA, myc-SNX1, or myc-
SNX1 siRNA-resistant mutant (siRNA-mut)
cDNAs (lanes 3–8). Cells were then incu-
bated in the presence or absence of 100 M
SFLLRN for 90 min at 37°C, lysed, and im-
munoprecipitated with M2 anti-FLAG anti-
body, and the amount of PAR1 remaining
was assessed by immunoblot with anti-PAR1
polyclonal antibody. Cell lysates were immu-
noblotted with anti-SNX1 antibody to detect
both endogenous and ectopically expressed
myc-SNX1 (middle panels) or actin expres-
sion to control for equal loading (bottom pan-
els). The results (mean  SE) shown are ex-
pressed as a percentage of PAR1 remaining
compared with untreated control and are the
average of three independent experiments.
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protein that was similar to that observed in control siRNA-
treated cells (Figure 5A), indicating that neither Hrs nor
Tsg101 is essential for degradation of PAR1. To exclude the
possibility of aberrant PAR1 degradation by proteases in a
nonlysosomal compartment formed in Hrs and Tsg101
knockdown cells, we examined PAR1 colocalization with
LAMP1 in the presence of leupeptin. In all cases, activated
PAR1 accumulated in vesicles and showed marked colocal-
ization with LAMP1 in the presence of leupeptin, whereas in
the absence of protease inhibitor, receptor-containing vesi-
cles were no longer detectable (Figure 5B). These results
suggest that activated PAR1 is targeted to lysosomes and
degraded in cells lacking endogenous Hrs and Tsg101. In
contrast to PAR1, however, activated EGFR degradation
was significantly inhibited in the same cells depleted of Hrs
and Tsg101 proteins (Figure 5C), consistent with previous
studies showing a requirement for Hrs and Tsg101 in EGFR
lysosomal sorting and degradation (Lu et al., 2003). These
data strongly suggest that SNX1 mediates sorting of PAR1 to
a lysosomal degradative pathway that is independent of Hrs
and Tsg101 proteins.
SNX2 Regulates Lysosomal Sorting of PAR1, But Is Not
Essential for This Process
SNX1 and SNX2 are highly homologous and display func-
tional redundancy in certain cellular processes (Schwarz et
al., 2002), suggesting that SNX2 might be involved in endo-
some-to-lysosome sorting of PAR1. Toward determining the
function of SNX2 in PAR1 trafficking, we initially assessed
the effect of SNX2 overexpression on agonist-induced PAR1
degradation. HeLa cells transiently cotransfected with
FLAG-tagged PAR1 and either SNX1 or pcDNA showed a
significant 50% degradation of PAR1 protein after expo-
sure to agonist (Figure 6A), consistent with our previously
published studies (Wang et al., 2002). In striking contrast,
however, agonist-induced degradation of PAR1 was mark-
edly inhibited in cells coexpressing SNX2 (Figure 6A, lanes
3–4), only 7% of receptors were degraded after 90-min in-
cubation with agonist. To determine whether SNX2 was
necessary for activated PAR1 degradation, we used siRNA
to deplete cells of endogenous SNX2 protein. In cells lacking
endogenous SNX2, agonist induced a significant 60% de-
crease in PAR1 protein that was comparable to that ob-
served in control siRNA-treated cells (Figure 6B), indicating
that SNX2 is not essential for sorting activated PAR1 to a
degradative pathway. These findings suggest that SNX2 is
capable of regulating PAR1 trafficking, but that it is not
required for this process.
To identify the domain(s) that specify the distinct func-
tions of SNX1 and SNX2 in regulation of PAR1 trafficking,
we generated chimeras in which the N- or C-terminal do-
mains of these proteins were exchanged (Figure 7A). HeLa
cells transiently cotransfected with FLAG-tagged PAR1 and
SNX1, SNX21 or SNX1/2 chimeras were incubated in the
absence or presence of agonist, and the effect on receptor
degradation was then assessed by immunoblot. Agonist in-
duced a comparable 60–70% decrease in PAR1 protein in
cells cotransfected with either wild-type SNX1, S1N-
S2PXC1, or S1NPX-S2C chimeras (Figure 7B, lanes 3 and 4,
and 9–12), suggesting that neither the SNX2 PX domain nor
C-terminus is sufficient to block PAR1 degradation. By con-
trast, activated PAR1 degradation was significantly inhib-
ited in cells coexpressing S2N-S1PXC or S2NPX-S1C chime-
ras containing either the SNX2 N-terminus or
N-terminal/PX domain (Figure 7B, lanes 5–8), similar to
that observed with wild-type SNX2 (Figure 7B, lanes 1 and
2). Together, these findings suggest that the amino-terminal
domain of SNX2 specifies its ability to inhibit activated
PAR1 sorting to a lysosomal degradative pathway.
Regulation of PAR1 Lysosomal Degradation by SNX2
Involves Disruption of Endogenous SNX1 Endosomal
Localization
SNX1 and SNX2 are capable of forming heterodimeric com-
plexes in vitro and in vivo (Haft et al., 1998; Wang et al., 2002;
Zhong et al., 2002), raising the possibility that SNX2 might
regulate activated PAR1 sorting via interaction with endog-
enous SNX1. We therefore examined whether ectopic ex-
pression of SNX2 affected endogenous SNX1 subcellular
localization using confocal microscopy. In untransfected
Figure 3. SNX1 is not essential for agonist-induced PAR1 internal-
ization. (A) PAR1-expressing HeLa cells were transiently trans-
fected with nonspecific (ns) or SNX1 siRNA and then incubated in
the absence or presence of 100 M SFLLRN for various times at
37°C. Cells were then fixed, and the amount of receptor remaining
on the cell surface was measured by ELISA. The initial level of PAR1
expressed on the cell surface before incubation at 37°C (0 min) was
similar for each transfection condition. These results (mean  SD)
are expressed as a fraction of M1 anti-FLAG antibody (antibody)
bound compared with total antibody bound to untreated control
cells and are representative of three independent experiments. (B)
PAR1-expressing HeLa cells were either left untreated (Ctrl) or
incubated with 100 M SFLLRN for 10 min or 60 min at 37°C. Cells
were fixed and immunostained for PAR1 and imaged by confocal
microscopy. The imaged cells are representative of many cells ex-
amined in at least three independent experiments. Scale bar, 10 m.
(C) Immunoblot analysis of lysates transfected with nonspecific (ns)
or SNX1 siRNA confirms the loss of endogenous SNX1 expression
(left). Immunofluorescence microscopy of HeLa cells transfected
with nonspecific (ns) or SNX1 siRNA is consistent with the loss of
endogenous SNX1 (right). The imaged cells are representative of
many cells examined in separate experiments. Scale bar, 10 m.
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HeLa cells, endogenous SNX1 localized primarily to endo-
somal vesicles, whereas in cells overexpressing wild-type
myc-SNX2 endosomal localization of endogenous SNX1 was
severely disrupted (Figure 8A, arrow). Immunoblot analysis
demonstrates a similar amount of endogenous SNX1 in myc-
SNX2 and vector-transfected cells (Figure 8B), suggesting
that endogenous SNX1 is likely mislocalized, but not de-
graded in cells overexpressing SNX2. The expression of
chimeras containing the SNX2 N-terminal domain or N-
terminal/PX domain also displaced endogenous SNX1, al-
beit less effectively than wild-type SNX2 (Figure 8C, a–d).
In contrast, overexpression of wild-type SNX1 failed to affect
endosomal location of endogenous SNX2 (Figure 8C, e and
f). These findings suggest that SNX2 might indirectly reg-
ulate PAR1 lysosomal sorting by disrupting endosomal lo-
calization of endogenous SNX1.
To determine whether targeting of SNX2 to endosomal
vesicles is required for inhibiting PAR1 degradation and for
disruption of endogenous SNX1 localization, we examined
the effect of a previously described SNX2 RRF mutant that
fails to localize to early endosomes (Gullapalli et al., 2004).
The SNX2 PX domain contains highly conserved R182RF184
residues that are critical for PtdIns(3)P binding and endoso-
mal localization (Worby and Dixon, 2002; Zhong et al., 2002).
Consistent with our findings described above, agonist-in-
duced PAR1 degradation was markedly inhibited in cells
overexpressing wild-type SNX2 compared with vector-
transfected cells (Figure 9A, lanes 1–4). In contrast, coex-
pression of SNX2 RRF mutant failed to inhibit activated
PAR1 degradation (Figure 9A, lanes 5 and 6). Moreover,
overexpression of SNX2 RRF mutant failed to disrupt en-
dosomal localization of endogenous SNX1 compared with
wild-type SNX2 (Figure 9B, a–f), suggesting that targeting
of SNX2 to endosomal membranes is critical for disrupting
localization of endogenous SNX1. Taken together these find-
ings provide further evidence that endosomal localization of
endogenous SNX1 is important for sorting activated PAR1
to a lysosomal degradative pathway.
Figure 4. Agonist-induced lysosomal degra-
dation of PAR1 in cells depleted of retromer.
(A) PAR1-expressing HeLa cells were tran-
siently transfected with nonspecific (ns) or
Vps26 siRNA and then incubated with or
without 100 M SFLLRN agonist peptide for
90 min at 37°C. Cell lysates were immunopre-
cipitated with M2 anti-FLAG antibody, and
the amount of PAR1 remaining was detected
by immunoblot. To confirm depletion of
Vps26 and Vps35 subunits by siRNA, cell ly-
sates were immunoblotted with anti-Vps26
and anti-Vps35 antibodies, respectively. Mem-
branes were stripped and reprobed with an
anti-actin antibody to control for equal load-
ing. The data (mean  SE) in the bar graph are
expressed as a percentage of PAR1 remaining
compared with untreated control cells. Data
were determined for each transfection condi-
tion and represent the average of three sepa-
rate experiments. (B) PAR1-expressing HeLa
cells transiently transfected with nonspecific
(ns) or Vps26 siRNA were preincubated in the
absence or presence of 2 mM leupeptin for 1 h
and then stimulated with 100 M SFLLRN for
60 min at 37°C. Cells were fixed and coimmu-
nostained for PAR1 (green) and LAMP1 (red)
and imaged by confocal microscopy. Colocal-
ization of PAR1 and LAMP1 is revealed by the
yellow color in the merged image (arrow-
heads). The insets are magnifications of boxed
areas. Scale bar, 10 m. The imaged cells are
representative of many cells examined in three
different experiments. (C) PAR1-expressing
HeLa cells transfected with either nonspecific
(ns) or Vps26 siRNA were incubated in the ab-
sence or presence of 10 M cycloheximide di-
luted in serum-free DMEM for 18 h and lysed,
and the amount of CI-MPR remaining was de-
termined by immunoblot analysis. Membranes
were striped and reprobed for actin expression
to control for equal loading. The expression of
SNX1, SNX2, and Vps26 was assessed in the
same cell lysates by immunoblot analysis. The
data (mean  SE) shown in the bar graph rep-
resent the percentage of CI-MPR remaining
compared with noncycloheximide-treated cells
for each transfection condition after normaliza-
tion to total actin expression. The data represent
the average of three separate experiments.
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DISCUSSION
In the present study, we have defined for the first time an
essential role for endogenous SNX1 in endosome-to-lyso-
some sorting of a cell surface receptor in mammalian cells.
We specifically show that SNX1 is necessary for sorting
activated PAR1 to a lysosomal degradative pathway in
HeLa cells. Interestingly, PAR1 lysosomal degradation does
not require retromer activity, suggesting that SNX1 has dis-
tinct functions in endosome-to-lysosome sorting and retro-
grade trafficking. Hrs and Tsg101 are also not essential for
activated PAR1 degradation, indicating that multiple dis-
tinct pathways exist for lysosomal sorting of cell surface
receptors in mammalian cells. In contrast to SNX1, however,
SNX2 is not required for PAR1 degradation, but can regulate
PAR1 lysosomal sorting through its ability to disrupt endo-
somal localization of endogenous SNX1. Analysis of chi-
meric SNX1/2 proteins suggest that regulation of PAR1
sorting by SNX2 is specified by the amino-terminal domain,
the least conserved region of these proteins with only 26%
identity at the amino acid level. Together these studies
strongly suggest an essential function for endogenous SNX1
in sorting PAR1 to a distinct lysosomal degradative pathway
that is independent of retromer, Hrs, and Tsg101 functions.
A recent study using RNAi and HeLa cells suggests that
SNX1 has retained a conserved function in endosome-to-
TGN retrograde trafficking in yeast and mammals (Carlton
et al., 2004). We also recently demonstrated that endogenous
SNX1 is not essential for lysosomal sorting of EGFR in HeLa
cells (Gullapalli et al., 2004). These studies suggested that
SNX1 might not function in endosome-to-lysosome sorting
of cell surface receptors in mammalian cells. However, we
report here that SNX1 is essential for sorting PAR1, a GPCR,
to a lysosomal degradative pathway. Depletion of endoge-
nous SNX1 by siRNA markedly inhibited activated PAR1
degradation, whereas receptor internalization was unaf-
fected. Moreover, expression of a SNX1 siRNA-resistant mu-
tant protein restored the ability of agonist to promote PAR1
degradation in cells lacking endogenous SNX1, strongly
suggesting that SNX1 is required for lysosomal sorting of
activated PAR1. We previously showed that EGFR degrada-
tion occurs normally in these same siRNA-transfected cells
depleted of endogenous SNX1 (Gullapalli et al., 2004), ex-
cluding the possibility of global defects in lysosomal degra-
dation. Moreover, SNX1-dependent lysosomal sorting of
PAR1 is consistent with our previous work in which we
showed that SNX1 associates with PAR1 and that a SNX1
Figure 5. Hrs and Tsg101 are not required
for lysosomal degradation of PAR1. (A)
PAR1-expressing HeLa cells transiently
transfected with nonspecific (ns), Hrs-, or
Tsg101-specific siRNAs were incubated in
the absence or presence of 100 M SFLLRN
for 90 min at 37°C, and the amount of PAR1
protein degradation was then assessed as de-
scribed above. Cell lysates were immuno-
blotted with anti-Hrs or -Tsg101 antibodies
to confirm loss of these proteins in siRNA-
transfected cells or for actin expression to
control for equal loading. The results
(mean  SE) shown in the graph are repre-
sented as a percentage of PAR1 remaining
compared with untreated control cells for
each transfection condition and are an aver-
age of at least three experiments. (B) PAR1-
expressing HeLa cells were treated with or
without 2 mM leupeptin and then incubated
with 100 M SFLLRN as described above.
Cells were fixed and coimmunostained for
PAR1 (green) and LAMP1 (red) and imaged
by confocal microscopy. Colocalization of
PAR1 and LAMP1 is revealed by the yellow
color in the merged image (arrowheads). The
insets are magnifications of boxed areas.
Scale bar, 10 m. (C) Serum-starved HeLa
cells transfected with Tsg101, Hrs, or nonspe-
cific (ns) siRNAs were incubated in the ab-
sence or presence of 100 ng/ml EGF ligand
for 30 min at 37°C, and the amount of recep-
tor protein remaining was then determined
by immunoblot analysis using anti-EGFR an-
tibodies. Cell lysates run in parallel were im-
munoblotted for Hrs and Tsg101 to confirm
loss of protein in siRNA-transfected cells or
for actin expression to control for equal load-
ing. Similar results were observed in three
separate experiments
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deletion mutant blocked degradation of activated PAR1
(Wang et al., 2002). These data strongly support a role for
SNX1 in endosome-to-lysosome sorting of a cell surface
GPCR in mammalian cells. Interestingly, SNX1 has recently
been shown to directly interact with the cytoplasmic car-
boxyl tail of at least 10 other distinct GPCRs in vitro (Hey-
dorn et al., 2004). However, whether SNX1 regulates intra-
cellular trafficking of these receptors remains to be
determined.
These studies also indicate that SNX1 is capable of regu-
lating distinct intracellular trafficking processes in mamma-
lian cells. Several recent studies showed that retromer
(Vps26 and Vps35 subunits) and SNX1 function in retro-
grade trafficking of CI-MPR in HeLa cells (Arighi et al., 2004;
Carlton et al., 2004; Seaman, 2004), analogous to regulation
of Vps10p receptor by the yeast retromer complex
(Horazdovsky et al., 1997; Nothwehr and Hindes, 1997; Sea-
man et al., 1998). In the studies reported here, we demon-
strate that activated PAR1 is efficiently degraded in cells
lacking Vps26 and Vps35 proteins, but not in cells depleted
of SNX1 protein, indicating that SNX1, and not retromer, is
important for PAR1 degradation. CI-MPR trafficking was
perturbed in cells depleted of Vps26 and Vps35, indicating
that retromer activity was indeed disrupted in these cells.
The ability of SNX1 and SNX2 to dimerize and the survival
of Snx1/ and Snx2/ null mice, but not the doubly defi-
cient Snx1/;Snx2/ mice (Schwarz et al., 2002), suggests
that the proteins may act together as a heterodimeric com-
plex or separately as a homodimer. Our studies indicate that
SNX2 is not essential for lysosomal sorting of PAR1, but it
can regulate PAR1 degradation by disrupting endosomal
localization of endogenous SNX1. The effect of SNX2 on
endogenous SNX1 localization is unlikely to involve gener-
alized disruption of the endocytic sorting machinery be-
cause overexpression of SNX2 does not induce extensive
tubulation or affect EGFR degradation (Gullapalli et al., 2004;
Carlton et al., 2005). Thus, lysosomal sorting of PAR1 ap-
pears to be regulated primarily by a homodimeric SNX1:
SNX1 complex, whereas SNX1:SNX2 heterodimeric com-
plexes may have other important functions in mammalian
cells. Indeed, our recent work with mice provides the first
genetic evidence for a mammalian retromer complex con-
taining SNX1 and SNX2, which has an essential role in
embryonic development that does not involve regulation of
CI-MPR trafficking (Griffin et al., 2005). In addition, the
mammalian retromer Vps35-Vps29-Vps26 subcomplex has
been shown to regulate transcytosis of the pIgR-pIgA recep-
tor in polarized epithelial cells independent of SNX1 and
SNX2 (Verges et al., 2004). Together these studies indicate
that SNX1 and retromer have evolved considerably from
yeast and have acquired a variety of distinct functions in
regulation of intracellular trafficking in mammalian cells.
Our studies further indicate that SNX1 mediates sorting of
activated PAR1 to a distinct lysosomal sorting pathway that
is independent of Hrs and Tsg101. The best-characterized
route from endosomes to lysosomes involves the formation
of early endosomal tubular extensions that mature into mul-
tivesicular bodies/late endosomes that then fuse with lyso-
somes. Sorting of EGFR through this pathway involves ubiq-
uitin-dependent interaction with Hrs/clathrin and Tsg101
(Raiborg et al., 2001; Bishop et al., 2002; Lu et al., 2003). Our
findings indicate that neither Hrs nor Tsg101 is essential for
activated PAR1 lysosomal degradation, whereas in the same
cells depleted of Hrs or Tsg101, degradation of EGFR is
significantly inhibited. Moreover, SNX1 is required for lyso-
somal degradation of PAR1, but is not involved in EGFR
degradation. In addition to PAR1, the delta opioid G pro-
tein-coupled receptor (DOR) does not require Tsg101 for
agonist-induced lysosomal degradation (Hislop et al., 2004).
This study also reported that lysosomal sorting of DOR is
dependent on Hrs. However, in this case, overexpression or
RNAi-mediated knockdown of Hrs appears to only partially
inhibit DOR degradation. Moreover, Hrs is involved in ly-
sosomal sorting of ubiquitinated membrane proteins, and
agonist-induced lysosomal degradation of DOR occurs in-
dependent of ubiquitin modification (Tanowitz and Von
Zastrow, 2002). Thus, DOR may follow a lysosomal sorting
pathway similar to PAR1. SNX1 has been shown to directly
bind to the DOR cytoplasmic tail in vitro (Heydorn et al.,
2004); however, whether SNX1 is required for lysosomal
degradation of DOR remains to be determined. Together,
Figure 6. SNX2 can regulate activated PAR1 degradation, but is
not required for this process. (A) HeLa cells transiently cotrans-
fected with FLAG-tagged PAR1 and either pcDNA, myc-SNX2 or
myc-SNX1 were incubated in the absence or presence of 100 M
SFLLRN for 90 min at 37°C. Cells were lysed and immunoprecipi-
tated, and the amount of PAR1 remaining was determined by
immunoblot. Cell lysates run in parallel were immunoblotted with
anti-myc antibody to confirm expression of SNX1 and SNX2 (bot-
tom panels). The data (mean  SE) shown in the bar graph are
represented as a percentage of PAR1 remaining compared with
untreated control cells and are an average of three separate exper-
iments. (B) HeLa cells stably expressing PAR1 were transfected with
nonspecific (ns) or SNX2 siRNA and treated with 100 M SFLLRN
for 90 min at 37°C, and the amount of PAR1 remaining was deter-
mined as described above. Cell lysates were immunoblotted with
SNX2-specific antibodies to confirm loss of protein or anti-actin
antibodies to control for equal loading. The results (mean  SE)
shown in the bar graph were derived as described above.
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these findings suggest that SNX1 regulates a distinct lyso-
somal sorting pathway that targets at least certain GPCRs
for degradation independent of Hrs and Tsg101.
The mechanism by which SNX1 regulates endosome-to-
lysosome sorting of PAR1 probably involves its localization
to and pinching off of PAR1-positive endosomal tubules.
Recent work indicates that SNX1 localization to early endo-
somes is mediated by two membrane binding domains, a PX
domain that interacts with PtdInsP and a BAR (Bin/Am-
phiphysin/Rvs) domain that allows SNX1 to dimerize and
to sense membrane curvature (Carlton et al., 2004). SNX1
binds to the tubular portion of early endosomes and forms
oligomers that may facilitate pinching off of endosomal tu-
bules. This process probably involves SNX1 interaction with
other proteins, because tubulation induced by SNX1 in vitro
is rather weak compared with Drosophila amphiphysin. In
addition, the localization of SNX1 to endosomal membranes
is not directly responsible for recruitment of PAR1, because
we, and others, have failed to detect a direct interaction
between PAR1 cytoplasmic domains and SNX1 (Heydorn et
Figure 7. Expression of SNX2 amino-termi-
nal domain chimeras inhibit activated PAR1
degradation. (A) Chimeras of SNX1 and
SNX2 were generated by exchanging either
the N-terminal or C-terminal domain. SNX1
bearing the N-terminus of SNX2 is desig-
nated “S2N-S1PXC”, and SNX2 containing
the SNX1 N-terminal domain is designated
“S1N-S2PXC”, whereas SNX1 containing the
SNX2 C-terminus is termed “S1NPX-S2C”,
and SNX2 with the SNX1 C-terminus is des-
ignated “S2NPX-S1C”. (B) HeLa cells were
transiently cotransfected with FLAG-tagged
PAR1 and cDNAs encoding either SNX1,
SNX2 or various SNX1/2 chimeras and then
incubated in the absence or presence of 100
M SFLLRN for 90 min at 37°C. Cell lysates
were immunoprecipitated with M2 anti-
FLAG antibody, and remaining PAR1 was
detected with anti-PAR1 polyclonal anti-
body. Cell lysates run in parallel were immu-
noblotted with anti-myc antibody to confirm
expression of various sorting nexins (lower
panel). The data (mean  SE) shown in the
graph are represented as a percentage of
PAR1 remaining compared with untreated
control cells determined for each transfection
condition and are the average of at least three
independent experiments.
Figure 8. Expression of SNX2 amino-termi-
nal domain chimeras disrupt endogenous
SNX1 endosomal localization. (A) HeLa cells
transiently transfected with myc-tagged
SNX2 wild-type or pcDNA were fixed and
immunostained for endogenous SNX1 (left
panel) and myc-tagged SNX2 (right panel).
The arrow indicates the localization of en-
dogenous SNX1 in myc-SNX2-transfected
cells. Scale bar, 10 m. (B) Cell lysates pre-
pared from pcDNA or myc-SNX2-transfected
cells were immunoblotted for endogenous
SNX1 using anti-SNX1-specific antibodies or
for myc-SNX2 expression using anti-myc an-
tibodies. (C) Cells transfected with myc-
tagged S2N-S1PXC or S2NPX-S1C chimera
were fixed and immunostained for endoge-
nous SNX1 (a and c) and myc-tagged SNX2
chimeric proteins (b and d), and imaged by
confocal microscopy. HeLa cells transiently
transfected with myc-SNX1 were fixed, im-
munostained for endogenous SNX2 or myc-
SNX1 (e and f, respectively). These images
are representative of many cells examined in
three separate experiments. Scale bar, 10 m.
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al., 2004). Thus, other proteins associated with SNX1 tubules
probably select cargo such as PAR1 for sorting from endo-
somes to lysosomes. One potential candidate that can medi-
ate transport of cargo from tubular sorting endosomes to
lysosomes is adaptor protein complex-3 (AP3) (Ihrke et al.,
2004; Peden et al., 2004). AP3-dependent lysosomal sorting
from tubular sorting endosomes is distinct from Hrs/
Tsg101-mediated trafficking via multivesicular bodies that
form by inward budding of the limiting membrane. The 3
subunit of AP3 binds directly to di-leucine- or tyrosine-
based sorting signals within the cytoplasmic regions of
transmembrane proteins. The cytoplasmic tail of PAR1 con-
tains two tyrosine-based motifs (Yxx) and we recently
demonstrated that the 2 subunit of AP2 binds directly to
the distal tyrosine-based motif to mediate PAR1constitutive
internalization, an important process for cellular recovery of
thrombin signaling (Paing et al., 2006). However, whether
AP3 can also bind directly to one or both of these tyrosine-
based motifs to promote lysosomal sorting of PAR1 remains
to be determined.
Our data suggest that SNX1 function is critical for lysoso-
mal sorting of PAR1 in HeLa cells, a human epithelial-like
cell line isolated from an adenocarcinoma. However, SNX1
lysosomal function is not solely responsible for the lethality
reported for Par1/ null mice, because Snx1/ mice are
normal and viable (Connolly et al., 1996; Schwarz et al.,
2002). By contrast, mice with targeted deletions for Par1 are
50% lethal at midgestation due to loss of PAR1 function in
endothelial cells, resulting in defective blood vessel forma-
tion and subsequent bleeding that occurs independent of
platelets (Connolly et al., 1996; Griffin et al., 2001). Platelets
are not present at midgestation and PAR1 is not expressed in
murine platelets. To date no mice have been generated with
defects in PAR1 lysosomal sorting and degradation. Thus,
perhaps Snx1/ mice do not share a similar phenotype of
embryonic lethality with Par1/ mice because PAR1 lyso-
somal degradation is not essential during embryonic devel-
opment. Alternatively, other compensatory mechanisms for
PAR1 lysosomal sorting and degradation could exist in the
mouse. Clearly, further analysis of PAR1 trafficking in en-
Figure 9. A SNX2 RRF mutant defective in
lipid-binding fails to disrupt activated PAR1
degradation and endogenous SNX1 endoso-
mal localization. (A) HeLa cells transiently
cotransfected with FLAG-tagged PAR1 and
either myc-SNX2, myc-SNX2RRF mutant,
or pcDNA were incubated in the absence or
presence of 100 M SFLLRN for 90 min at
37°C. Cell lysates were immunoprecipitated
with M2 anti-FLAG antibody, and the re-
maining PAR1 was detected by immunoblot-
ting with anti-PAR1 polyclonal antibody (top
panels). The expression of myc-SNX2 wild-
type or mutant in total cell lysates was de-
tected with anti-myc antibody (lower panel).
The results (mean  SE) in the bar graph
shown are expressed as a percentage of PAR1
remaining compared with untreated control
cells determined for each transfection condi-
tion and are the average of three independent
experiments. (B) HeLa cells transiently trans-
fected with myc-SNX2 or myc-SNX2RRF
mutant were fixed and coimmunostained for
endogenous SNX1 or myc-tagged SNX2 and
imaged by confocal microscopy. Endogenous
SNX1 and myc-SNX2 wild-type or mutant
localization are shown together in the
merged image. These images are representa-
tive of many cells examined in at least three
different experiments. Scale bar, 10 m.
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dothelial cells lacking SNX1 would help integrate our find-
ings in HeLa cells with the existing genetic data reported for
Par1/ and Snx1/ null mice.
In summary, our studies demonstrate for the first time an
essential role for endogenous SNX1 in endosome-to-lyso-
some sorting of a cell surface receptor in mammalian cells.
Moreover, endogenous SNX1 is necessary for sorting PAR1
to a distinct lysosomal degradative pathway that is indepen-
dent of retromer, Hrs and Tsg101, whether PAR1 sorting to
lysosomes involves transit through multivesicular bodies is
not known. These findings bring important insight into how
PAR1, and perhaps other GPCRs, are sorted from endo-
somes to lysosomes and degraded. The challenge now be-
comes to elucidate the mechanism by which PAR1, and
perhaps other GPCRS, are recruited to the distinct SNX1-
dependent lysosomal sorting degradative pathway.
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